Recent Developments in the Pathology of Thyroid Cancer

Ahn, 2014, Korea's thyroid-cancer “epidemic” – screening and overdiagnosis, N Engl J Med, 371, 1765, 10.1056/NEJMp1409841 Kitahara, 2016, The changing incidence of thyroid cancer, Nat Rev Endocrinol, 26, 1 The Royal College of Pathologists, 2014 Seethala, 2016 Perros, 2014, Guidelines for the management of thyroid cancer, Clin Endocrinol, 81, 1, 10.1111/cen.12515 Sobrinho-Simőes, 2011, Follicular thyroid carcinoma, Mod Pathol, 24, S10, 10.1038/modpathol.2010.133 Elsheikh, 2008, Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma, Am J Clin Pathol, 130, 736, 10.1309/AJCPKP2QUVN4RCCP Cipriani, 2015, Follicular thyroid carcinoma: how have histologic diagnoses changed in the last half-century and what are the prognostic implications, Thyroid, 25, 1209, 10.1089/thy.2015.0297 LiVolsi, 2010, Papillary carcinoma tall cell variant (TCV): a review, Endocr Pathol, 21, 12, 10.1007/s12022-010-9106-y Nikiforov, 2016, Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma – a paradigm shift to reduce overtreatment of indolent tumours, JAMA Oncol, 2, 1023, 10.1001/jamaoncol.2016.0386 The Royal College of Pathologists, 2016 Faquin, 2016, Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda system for reporting thyroid cytology, Cancer Cytopathol, 124, 181, 10.1002/cncy.21631 LiVolsi, 2011, Follicular-patterned tumors of the thyroid: the battle of benign vs malignant vs so-called uncertain, Endocr Pathol, 22, 184, 10.1007/s12022-011-9183-6 Mete, 2011, Pathological definition and clinical significance of vascular invasion in thyrid carcinomas of follicular epithelial derivation, Mod Pathol, 12, 1545, 10.1038/modpathol.2011.119 Goffredo, 2013, Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients, Ann Surg Oncol, 20, 767, 10.1245/s10434-012-2697-4 O'Neill, 2011, Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion, Eur J Surg Onol, 37, 181, 10.1016/j.ejso.2010.11.005 Sugino, 2012, Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma, Thyroid, 22, 798, 10.1089/thy.2012.0051 Volante, 2007, Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach, Am J Surg Pathol, 31, 1256, 10.1097/PAS.0b013e3180309e6a Volante, 2010, Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours, Endocr Pathol, 21, 1, 10.1007/s12022-009-9100-4 Choi, 2013, Clinical significance of microscopic anaplastic focus in papillary thyroid carcinoma, Surgery, 154, 106, 10.1016/j.surg.2013.02.018 Eloy, 2016, Newly diagnosed thyroid tumours and variants, Diagn Histopathol, 22, 179, 10.1016/j.mpdhp.2016.04.011 Mete, 2010, Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension, Ann Surg Oncol, 17, 386, 10.1245/s10434-009-0832-7 Su, 2016, Inter-observer variation in the pathologic identification of minimal extrathyroidal extension in papillary thyroid carcinoma, Thyroid, 26, 512, 10.1089/thy.2015.0508 Arora, 2008, Extrathyroidal extension is not all equal: implications of macroscopic versus microscopic extent in papillary thyroid carcinoma, Surgery, 144, 942, 10.1016/j.surg.2008.07.023 Randolph, 2012, The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension, Thyroid, 2, 1144, 10.1089/thy.2012.0043 Vas Nunes, 2013, Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma, Thyroid, 23, 811, 10.1089/thy.2012.0460 Rajeev, 2013, The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid carcinoma, Langenbecks Arch Surg, 398, 377, 10.1007/s00423-012-1041-6 Lang, 2012, Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma, Ann Surg Oncol, 19, 3472, 10.1245/s10434-012-2385-4 The Royal College of Pathologists, 2016 Gerhard, 2014, The value of second opinion in thyroid cytology: a review, Cancer Cytopathol, 122, 611, 10.1002/cncy.21436 Poller, 2016, Thyroid FNA: new classifications and new interpretations, Cancer Cytopathol, 124, 457, 10.1002/cncy.21703 The Cancer Genome Atlas Research Network, 2014, Integrated genomic characterization of papillary thyroid carcinoma, Cell, 159, 676, 10.1016/j.cell.2014.09.050 Nishino, 2016, Molecular cytopathology for thyroid nodules: a review of methodology and test performance, Cancer (Cancer Cytopathol), 124, 14, 10.1002/cncy.21612 Ferris, 2015, American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making, Thyroid, 25, 760, 10.1089/thy.2014.0502 Nikiforov, 2014, Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay, Cancer, 120, 3627, 10.1002/cncr.29038 Nikiforova, 2013, Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer, J Clin Endocrinol Metab, 98, E1852, 10.1210/jc.2013-2292 Nikifirov, 2011, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples, J Clin Endocrinol Metab, 96, 3390, 10.1210/jc.2011-1469